TY - JOUR
T1 - Acupuncture for polycystic ovary syndrome : a cross-sectional survey of clinical practice amongst acupuncturists trained in reproductive medicine
AU - Graca, Sandro
AU - Armour, Mike
AU - McClure, Lara
PY - 2022
Y1 - 2022
N2 - Introduction: Polycystic ovary syndrome (PCOS) is a complex lifelong disorder. While previous research reported on the effectiveness of acupuncture for PCOS symptoms, robust information on how PCOS is treated in community clinical practice remains sparse. This study explores how practitioners with training and certification in biomedicine and acupuncture for menstrual and reproductive health, American Board of Oriental Reproductive Medicine (ABORM) Fellows, approach the treatment of people with PCOS within the acupuncture clinic setting. Methods: Between February and March 2020, ABORM Fellows (n=346) received a link to an online survey collecting characteristics of point selection, rationale, treatment frequency, and outcome measures used. Quantitative data was analysed using descriptive statistics. Qualitative data was coded, checked for interrater reliability, and analysed using a qualitative descriptive approach. Results: One hundred and twenty-seven ABORM Fellows responded (36.7%). Practitioners reported a pragmatic approach to the treatment of PCOS in their acupuncture clinics, consistent with practising using a partnership model, especially with respect to treatment timings and frequency, often dictated by their patients’ practical and financial considerations. Acupuncture points SP6 (Sanyinjiao), SP9 (Yinlingquan), LR3 (Taichong), EX-CA-1 (Zigong), and CV4 (Guanyuan) were commonly used, following a combination of rationales provided including Drain Damp, Tonify the Spleen, and both Qi and blood movement. Local anatomy, timing of ovulation, and knowledge from research literature on acupuncture for PCOS also influenced point selection rationale. Conclusions: When treating PCOS in clinical practice, ABORM Fellows rely on both traditional and modern aspects of acupuncture and biomedicine to inform diagnosis, treatment, and outcome measures.
AB - Introduction: Polycystic ovary syndrome (PCOS) is a complex lifelong disorder. While previous research reported on the effectiveness of acupuncture for PCOS symptoms, robust information on how PCOS is treated in community clinical practice remains sparse. This study explores how practitioners with training and certification in biomedicine and acupuncture for menstrual and reproductive health, American Board of Oriental Reproductive Medicine (ABORM) Fellows, approach the treatment of people with PCOS within the acupuncture clinic setting. Methods: Between February and March 2020, ABORM Fellows (n=346) received a link to an online survey collecting characteristics of point selection, rationale, treatment frequency, and outcome measures used. Quantitative data was analysed using descriptive statistics. Qualitative data was coded, checked for interrater reliability, and analysed using a qualitative descriptive approach. Results: One hundred and twenty-seven ABORM Fellows responded (36.7%). Practitioners reported a pragmatic approach to the treatment of PCOS in their acupuncture clinics, consistent with practising using a partnership model, especially with respect to treatment timings and frequency, often dictated by their patients’ practical and financial considerations. Acupuncture points SP6 (Sanyinjiao), SP9 (Yinlingquan), LR3 (Taichong), EX-CA-1 (Zigong), and CV4 (Guanyuan) were commonly used, following a combination of rationales provided including Drain Damp, Tonify the Spleen, and both Qi and blood movement. Local anatomy, timing of ovulation, and knowledge from research literature on acupuncture for PCOS also influenced point selection rationale. Conclusions: When treating PCOS in clinical practice, ABORM Fellows rely on both traditional and modern aspects of acupuncture and biomedicine to inform diagnosis, treatment, and outcome measures.
UR - https://hdl.handle.net/1959.7/uws:65732
U2 - 10.1016/j.eujim.2022.102161
DO - 10.1016/j.eujim.2022.102161
M3 - Article
VL - 54
JO - European Journal of Integrative Medicine
JF - European Journal of Integrative Medicine
M1 - 102161
ER -